- Home
- SCNI vs MTNB Comparison
SCNI vs MTNB Comparison
Compare SCNI & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- MTNB
- Stock Information
- Founded
- SCNI 2003
- MTNB 2013
- Country
- SCNI Israel
- MTNB United States
- Employees
- SCNI N/A
- MTNB N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- SCNI Health Care
- MTNB Health Care
- Exchange
- SCNI Nasdaq
- MTNB Nasdaq
- Market Cap
- SCNI 3.2M
- MTNB 3.6M
- IPO Year
- SCNI N/A
- MTNB N/A
- Fundamental
- Price
- SCNI $2.47
- MTNB $0.92
- Analyst Decision
- SCNI
- MTNB Hold
- Analyst Count
- SCNI 0
- MTNB 1
- Target Price
- SCNI N/A
- MTNB N/A
- AVG Volume (30 Days)
- SCNI 1.1M
- MTNB 539.0K
- Earning Date
- SCNI 08-14-2025
- MTNB 08-13-2025
- Dividend Yield
- SCNI N/A
- MTNB N/A
- EPS Growth
- SCNI N/A
- MTNB N/A
- EPS
- SCNI N/A
- MTNB N/A
- Revenue
- SCNI $658,000.00
- MTNB N/A
- Revenue This Year
- SCNI N/A
- MTNB N/A
- Revenue Next Year
- SCNI N/A
- MTNB N/A
- P/E Ratio
- SCNI N/A
- MTNB N/A
- Revenue Growth
- SCNI N/A
- MTNB N/A
- 52 Week Low
- SCNI $1.90
- MTNB $0.47
- 52 Week High
- SCNI $8.92
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- SCNI 49.52
- MTNB 55.38
- Support Level
- SCNI $2.15
- MTNB $0.87
- Resistance Level
- SCNI $2.70
- MTNB $1.04
- Average True Range (ATR)
- SCNI 0.22
- MTNB 0.10
- MACD
- SCNI 0.01
- MTNB -0.01
- Stochastic Oscillator
- SCNI 32.99
- MTNB 24.61
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.